By MedCloudInsider Editors
Findings highlight metabolic signatures linked to severe neurotoxicity, advancing understanding of CAR-T treatment risks.
Read Now
By MedCloudInsider Editors
New platform applies AI and robotics to streamline experiment execution and reduce manual lab work.
Read Now
By MedCloudInsider Editors
Findings support therapeutic targets for vanoglipel and reinforce AI’s role in early-stage drug development.
Read Now
By MedCloudInsider Editors
Agreement deepens long-term partnership as pharma companies increasingly turn to AI to speed early-stage drug discovery.
Read Now
By MedCloudInsider Editors
New platform applies net water uptake analysis to improve stroke assessment and treatment decision-making.
Read Now
By MedCloudInsider Editors
New offering combines iPSC technology and AI-driven editing design to support translational and clinical research.
Read Now
By MedCloudInsider Editors
New NOA Guide applies epigenetic analysis to help clinicians better evaluate non-obstructive azoospermia.
Read Now
By MedCloudInsider Editors
Providers increasingly view AI as critical for improving clinical outcomes, workforce efficiency and access to care.
Read Now
By MedCloudInsider Editors
Company moves AI-driven neuroscience platform from federally funded research into a commercial pipeline targeting a major unmet need.
Read Now
By John K. Waters
AstraZeneca has acquired Boston-based Modella AI to integrate the startup's pathology-focused artificial intelligence tools and multimodal foundation models into its oncology research and development operations, marking the drugmaker's first AI acquisition.
Read Now